Current trend in treatment of glioblastoma in Japan: a national survey using the diagnostic procedure combination database (J-ASPECT study-glioblastoma)

BACKGROUND: In the treatment for glioblastoma (GBM), treatment modalities, such as bevacizumab (BEV) and carmustine wafers implants have been approved in Japan since 2013. However, it is unclear whether such a trend in treatment complexity can accelerate treatment centralization. The aim of this stu...

Descripción completa

Detalles Bibliográficos
Autores principales: Funakoshi, Yusuke, Hata, Nobuhiro, Kuga, Daisuke, Hatae, Ryusuke, Sangatsuda, Yuhei, Fujioka, Yutaka, Takigawa, Kosuke, Yoshimoto, Koji, Mizoguchi, Masahiro, Iihara, Koji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Singapore 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8286941/
https://www.ncbi.nlm.nih.gov/pubmed/33974184
http://dx.doi.org/10.1007/s10147-021-01929-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8286941/
https://www.ncbi.nlm.nih.gov/pubmed/33974184
http://dx.doi.org/10.1007/s10147-021-01929-5

Ejemplares similares